Chabiotech Co.,Ltd. (KOSDAQ:085660)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Other			46.02B	41.68B	37.95B	32.97B	29.41B
Other Growth			10.41%	9.82%	15.13%	12.09%	-25.89%
Health Care			906.26B	808.25B	693.47B	634.94B	501.73B
Health Care Growth			12.13%	16.55%	9.22%	26.55%	12.89%
Finance			11.91B	3.14B	5.13B	2.89B	9.17B
Finance Growth			279.56%	-38.79%	77.44%	-68.49%	30.45%
Internal Sales			-10.24B	-8.48B	-9.07B	-6.08B	-5.69B
Total			953.95B	844.58B	727.48B	664.72B	534.61B
Total Growth			12.95%	16.10%	9.44%	24.34%	9.42%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States of America			635.11B	591.04B	512.62B	488.32B	361.98B
United States of America Growth			7.46%	15.30%	4.98%	34.90%	13.14%
Singapore			64.80B	57.41B	43.43B	30.06B	-
Singapore Growth			12.88%	32.19%	44.47%	-	-
Japan			2.76B	515.62M	157.86M	108.24M	1.19B
Japan Growth			435.69%	226.62%	45.85%	-90.91%	-69.69%
South Korea			261.52B	204.10B	180.34B	152.30B	155.20B
South Korea Growth			28.13%	13.17%	18.41%	-1.87%	3.81%
Unallocated			-10.24B	-8.48B	-9.07B	-6.08B	-5.69B
Singapore & Australia			-	-	-	-	21.93B
Singapore & Australia Growth			-	-	-	-	23.42%
Total			953.95B	844.58B	727.48B	664.72B	534.61B
Total Growth			12.95%	16.10%	9.44%	24.34%	9.42%

Source: S&P Global Market Intelligence.